Covidien's Restoril Dose Patent Deemed Obvious
A federal judge has handed victory to defendant URL Pharma Inc. in its battle with Covidien PLC over a generic version of the sleep aid Restoril, rendering the patent Covidien was...To view the full article, register now.
Already a subscriber? Click here to view full article